01-09-2026 14:00 via wallstreet-online.de

Valion Bio Announces Changes to Management and Board of Directors

Current CFO, Lisa Wolf named President and COO, assuming expanded executive and operational leadership. Jared Malbin and Thomas Jensen appointed as directors.Lead Asset Positioned for Significant Markets: Entolimod targets the projected $7.8 billion …
Weiterlesen »